The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status

American Journal of Obstetrics and Gynecology
J GilabertM Tortajada

Abstract

The aim of this study was to analyze several fibrinolytic components and coagulation inhibitors in postmenopausal women and had to evaluate the effect of hormone replacement therapy. Several hemostatic parameters were evaluated in 75 postmenopausal women before and after 3 to 4 and 12 months of hormone therapy. An increase in plasma fibrinolytic activity primarily related to a significant increase in tissue-type plasminogen activator and a decrease in plasminogen activator inhibitor type 1 was observed in women receiving hormone replacement therapy. A significant decrease in protein S and lipoprotein(a) was detected under therapy. No modifications in tissue-type plasminogen activator/plasminogen activator inhibitor-1 and activated protein C/alpha 1-antitrypsin complexes, urokinase activity, plasminogen, and antithrombin III were detected. The increase in fibrinolytic activity and the decrease in lipoprotein(a) levels observed in women receiving hormone replacement therapy could help decrease the risk of coronary disease associated with the postmenopausal state.

References

May 1, 1991·American Journal of Obstetrics and Gynecology·F EspañaJ H Griffin
Jun 1, 1994·European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies·J W van WerschA van Enk
Oct 1, 1993·The American Journal of the Medical Sciences·M E CarrS L Zekert
Dec 1, 1993·American Journal of Obstetrics and Gynecology·A A SalehE F Mammen

❮ Previous
Next ❯

Citations

Apr 1, 1997·The American Journal of Cardiology·J M SullivanK B Ramanathan
Dec 31, 2003·The Journal of Surgical Research·Lauren BakerDaniel R Meldrum
Oct 20, 2001·Diabetes Research and Clinical Practice·S L PalinA H Barnett
Nov 20, 1998·Maturitas·G Samsioe
Dec 12, 2002·Journal of the American College of Cardiology·LeRoy E RabbaniElsa-Grace V Giardina
May 24, 2003·Best Practice & Research. Clinical Endocrinology & Metabolism·Roger E Peverill
Aug 31, 2001·Menopause : the Journal of the North American Menopause Society·F P ChenK E Huang
Jan 15, 2002·The Australian & New Zealand Journal of Obstetrics & Gynaecology·I S SerinM Tayyar
Nov 5, 2002·Journal of Clinical Pharmacology·James P TsikourisGary E Meyerrose
Dec 7, 2007·Journal of Thrombosis and Thrombolysis·Daniela Amorim Melgaço GuimarãesAna Paula Fernandes
Mar 26, 2002·Climacteric : the Journal of the International Menopause Society·E FarishD M Hart
Jul 15, 2015·Journal of Neurosurgery·Adnan I QureshiM Fareed K Suri
Aug 12, 2009·Clinics in Laboratory Medicine·Bernard Khor, Elizabeth M Van Cott
Sep 14, 2007·Climacteric : the Journal of the International Menopause Society·N C KeramarisG C Creatsas
Dec 31, 1997·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·C P SpencerJ C Stevenson
Mar 12, 2003·Hematology/oncology Clinics of North America·Hau C Kwaan, Chadi Nabhan
Jun 10, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·D M HerringtonD B MacLean
May 16, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·H J TeedeR E Peverill
Oct 22, 2002·American Journal of Physiology. Endocrinology and Metabolism·Greta L HoetzerChristopher A DeSouza
Jan 25, 2003·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Michel M L HanssMarc Dechavanne
Sep 25, 2001·Journal of Applied Physiology·R K Dubey, E K Jackson
Feb 22, 2001·American Journal of Physiology. Renal Physiology·R K Dubey, E K Jackson
Nov 8, 2002·Archives of Pathology & Laboratory Medicine·Andrew J GoodwinEdwin G Bovill

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.